Insiders · Profile

Riccitelli Samuel D

President & CEO at Viridian Therapeutics, Inc.\DE. Filing since 19 Nov 2015. CIK 0001414839

Company
Date
Role
Action
Shares
Amount
Of holding
20 Nov 2015
President & CEO
Bought
7,000
$5.60K
2.1%
19 Nov 2015
President & CEO
Bought
7,000
$5.46K
2.1%
2 decisions on file.